You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Y90-Radioembolization

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HepatoCellular Carcinoma Trial in Singapore (Y-90 Radioembolization, Nivolumab)

Active, not recruiting
  • HepatoCellular Carcinoma
  • Singapore, Singapore
    National Cancer Centre - Singapore
May 25, 2022

Liver Cancer Trial in Houston (device, diagnostic test, procedure)

Not yet recruiting
  • Liver Cancer
  • TriSalus™ TriNav™Infusion System
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Feb 23, 2023

Colorectal Cancer Metastatic, Colon Cancer, Metastatic Colorectal Cancer Trial in Iowa City (Durvalumab, Yttrium-90

Recruiting
  • Colorectal Cancer Metastatic
  • +9 more
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Mar 24, 2022

Carcinoma, Hepatocellular Trial (Therasphere 90Y, Microwave Ablation)

Not yet recruiting
  • Carcinoma, Hepatocellular
  • Therasphere 90Y
  • Microwave Ablation
  • (no location specified)
Jul 12, 2023

Metastatic Liver Carcinoma, Stage IV Liver Cancer, Stage IVA Liver Cancer Trial in Houston (procedure, radiation, other)

Active, not recruiting
  • Metastatic Liver Carcinoma
  • +3 more
  • Angiography
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Cancer Trial in Manchester (Y90-PET-CT scan)

Recruiting
  • Cancer
  • Y90-PET-CT scan
  • Manchester, United Kingdom
    The Christie NHS - Nuclear Medicine Department
Nov 7, 2023

HCC, Cancer of Liver, Cancer Trial in Atlanta (SIR-Spheres microspheres)

Completed
  • HCC
  • +2 more
  • SIR-Spheres microspheres
  • Atlanta, Georgia
  • +2 more
Dec 22, 2021

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Carcinoma in the Liver Trial in Atlanta

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Y-90 SIR-Spheres
  • +2 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jun 7, 2022

Locally Advanced Intrahepatic Cholangiocarcinoma, Oligometastatic Intrahepatic Cholangiocarcinoma, Stage III Intrahepatic

Not yet recruiting
  • Locally Advanced Intrahepatic Cholangiocarcinoma
  • +4 more
  • Angiography
  • +8 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Sep 22, 2023

Colon Cancer, Rectal Cancer, Liver Metastases Trial in San Francisco (Tas-102, SIR-Sphere)

Completed
  • Colon Cancer
  • +2 more
  • San Francisco, California
    University of California San Francisco
Jul 28, 2022

Optimizing Y90 Therapy for Radiation Lobectomy

Recruiting
  • HCC
  • +4 more
  • Y90 radioembolization
  • Chicago, Illinois
    Northwestern University
Aug 27, 2021

Biopsy After Radioembolization to Identify Changes in Tumor

Recruiting
  • Colon Cancer Liver Metastasis
  • +5 more
  • Y90 TARE
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 30, 2022

Neuroendocrine Tumor Grade 2, Neuroendocrine Tumors Trial in Little Rock, Buffalo, Philadelphia (Capecitabine Oral Product,

Recruiting
  • Neuroendocrine Tumor Grade 2
  • Neuroendocrine Tumors
  • Capecitabine Oral Product
  • +2 more
  • Little Rock, Arkansas
  • +2 more
Aug 11, 2022

Metastatic Malignant Tumor in the Liver, Neuroendocrine Tumor Trial in San Francisco (procedure, biological, device)

Recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • Neuroendocrine Neoplasm
  • Arterial Embolization
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Dec 22, 2022

Hepatocellular Carcinoma Trial in Philadelphia (Yttrium-90 Microsphere Radioembolization, Perflutren Protein-Type A

Recruiting
  • Hepatocellular Carcinoma
  • Yttrium-90 Microsphere Radioembolization
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Nov 2, 2021

Hepatocellular Carcinoma, Stage I Hepatocellular Carcinoma AJCC v8, Stage IA Hepatocellular Carcinoma AJCC v8 Trial in Portland

Not yet recruiting
  • Hepatocellular Carcinoma
  • +8 more
  • Quality of Life
  • +3 more
  • Portland, Oregon
  • +1 more
Jun 20, 2022

Intrahepatic Cholangiocarcinoma Trial in Charleston (SIR-Spheres microspheres (Yttrium-90 Microspheres), Gemcitabine, Cisplatin)

Active, not recruiting
  • Intrahepatic Cholangiocarcinoma
  • SIR-Spheres microspheres (Yttrium-90 Microspheres)
  • +2 more
  • Charleston, South Carolina
    Medical University of South Carolina
Nov 11, 2021

Neuroendocrine Tumors, Gastrointestinal Tumors, Carcinoid Tumors Trial in Denver, Kansas City, Nashville (Lanreotide, Y-90

Terminated
  • Neuroendocrine Tumors
  • +2 more
  • Denver, Colorado
  • +2 more
Jul 5, 2022

Intrahepatic Cholangiocarcinoma Trial in Fairfax (Induction Chemotherapy Triplet Therapy, Concurrent Y-90 treatment,

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Induction Chemotherapy Triplet Therapy
  • +2 more
  • Fairfax, Virginia
    Inova Schar Cancer Institute
Jun 14, 2022

Hepatocellular Carcinoma, Hepatocellular Carcinoma Non-resectable, Liver Cancer Trial (EYE90 Microspheres Treatment)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • EYE90 Microspheres Treatment
  • (no location specified)
Jul 12, 2023

RadioEmbolization for ADvancement of Y90 Glass Microspheres

Terminated
  • Liver Cancer
  • TheraSphere®
  • Los Angeles, California
  • +7 more
Apr 19, 2021

Hepatocellular Carcinoma (HCC) Trial (Durvalumab, Bevacizumab, Transarterial Radioembolization (TARE))

Not yet recruiting
  • Hepatocellular Carcinoma (HCC)
  • (no location specified)
Sep 11, 2023

CT Perfusion and Post Y-90 TARE PET/CT Dosimetry

Withdrawn
  • Hepatocellular Carcinoma
  • CT Liver Perfusion
  • PET/CT of liver
  • Chicago, Illinois
    Rush University Medical Center
Oct 5, 2020

Thrombocytopenia, Cirrhosis Trial in Chicago (TheraSphere® Yttrium-90 Glass Microspheres, BTG International Inc.)

Recruiting
  • Thrombocytopenia
  • Cirrhosis
  • TheraSphere® Yttrium-90 Glass Microspheres, BTG International Inc.
  • Chicago, Illinois
    Northwestern University/Northwestern Memorial Hospital
Sep 7, 2022

Resectable Hepatocellular Carcinoma, Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Boston (Durvalumab, Tremelimumab,

Not yet recruiting
  • Resectable Hepatocellular Carcinoma
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 18, 2023